These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1801068)

  • 21. [Treatment of Paget's disease with 1-ethane-1-hydroxy-1-diphosphonate].
    Renier JC; Bontoux-Carre E; Bontoux L; Basle M; Moreau R; Jallet P
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):87-92. PubMed ID: 6801754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
    Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
    Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
    Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
    Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Paget's disease: errors to be avoided].
    Fournié A; Fournié B; Lassoued S
    Rev Prat; 1989 Apr; 39(13):1143-6. PubMed ID: 2499920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paget's disease of bone and basilar impression associated with an Arnold-Chiari type-1 malformation].
    Iglesias-Osma C; Gómez Sánchez JC; Suquia Múgica B; Querol Prieto R; de Portugal Alvarez J
    An Med Interna; 1997 Oct; 14(10):519-22. PubMed ID: 9424143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
    Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
    Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
    [No Abstract]   [Full Text] [Related]  

  • 28. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R; Baldauf G
    Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
    Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
    Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
    Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
    Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Dunn CJ; Fitton A; Sorkin EM
    Drugs Aging; 1994 Dec; 5(6):446-74. PubMed ID: 7858370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The long-term results of ethanehydroxydiphosphonate treatment in Paget's disease of bone].
    Morales Piga A; Corres González J; Pérez Ruiz F
    Rev Clin Esp; 1991 Oct; 189(5):213-7. PubMed ID: 1801068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.